A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine

MenB-4C (Bexsero; GlaxoSmithKline Biologicals) is a licensed meningococcal vaccine for capsular B strains. The vaccine contains detergent-extracted outer membrane vesicles (dOMV) and three recombinant proteins, of which one is factor H binding protein (FHbp). In previous studies, overexpression of F...

Descripción completa

Detalles Bibliográficos
Autores principales: Beernink, Peter T., Vianzon, Vianca, Lewis, Lisa A., Moe, Gregory R., Granoff, Dan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581866/
https://www.ncbi.nlm.nih.gov/pubmed/31213564
http://dx.doi.org/10.1128/mBio.01231-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581866/
https://www.ncbi.nlm.nih.gov/pubmed/31213564
http://dx.doi.org/10.1128/mBio.01231-19

Ejemplares similares